Your browser doesn't support javascript.
loading
Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis.
Rademacher, Jessica; Martin, Luise; Theloe, Anja; Stahl, Mirjam; Mall, Marcus A; Joean, Oana; Fuge, Jan; Hansen, Gesine; Welte, Tobias; Schütz, Katharina; Ringshausen, Felix C; Dittrich, Anna M.
Afiliação
  • Rademacher J; Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
  • Martin L; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
  • Theloe A; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine and Cystic Fibrosis Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Stahl M; DZL, associated partner site, Berlin, Germany.
  • Mall MA; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Joean O; Pharmacy Department, Charité - Universitätsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Fuge J; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine and Cystic Fibrosis Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Hansen G; DZL, associated partner site, Berlin, Germany.
  • Welte T; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Schütz K; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine and Cystic Fibrosis Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Ringshausen FC; DZL, associated partner site, Berlin, Germany.
  • Dittrich AM; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
ERJ Open Res ; 9(4)2023 Jul.
Article em En | MEDLINE | ID: mdl-37650087
AMS in chronic lung disease can be challenging. Causal treatment of treatable traits may be the most successful AMS strategy for patients with any chronic pulmonary disease and should be brought into focus. https://bit.ly/3ptrmV8.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article